CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma

NCT02484391 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Granulocytic Sarcoma
Recurrent Adult Acute Myeloid Leukemia

Interventions

DRUG: 6,8-Bis(benzylthio)octanoic Acid
DRUG: Cytarabine
PROCEDURE: Hematopoietic Cell Transplantation
DRUG: Mitoxantrone Hydrochloride

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]